HK1137344A1 - Tape preparation - Google Patents

Tape preparation

Info

Publication number
HK1137344A1
HK1137344A1 HK10101103.0A HK10101103A HK1137344A1 HK 1137344 A1 HK1137344 A1 HK 1137344A1 HK 10101103 A HK10101103 A HK 10101103A HK 1137344 A1 HK1137344 A1 HK 1137344A1
Authority
HK
Hong Kong
Prior art keywords
tape preparation
tape
preparation
Prior art date
Application number
HK10101103.0A
Other languages
English (en)
Inventor
Hiroo Maeda
Naoki Ohara
Original Assignee
Dainippon Sumitomo Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Sumitomo Pharma Co filed Critical Dainippon Sumitomo Pharma Co
Publication of HK1137344A1 publication Critical patent/HK1137344A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK10101103.0A 2006-06-09 2010-02-01 Tape preparation HK1137344A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2006161072 2006-06-09
JP2006232926 2006-08-30
PCT/JP2007/061538 WO2007142295A1 (ja) 2006-06-09 2007-06-07 新規テープ製剤

Publications (1)

Publication Number Publication Date
HK1137344A1 true HK1137344A1 (en) 2010-07-30

Family

ID=38801541

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10101103.0A HK1137344A1 (en) 2006-06-09 2010-02-01 Tape preparation

Country Status (13)

Country Link
US (1) US8354121B2 (xx)
EP (1) EP2036559B1 (xx)
JP (1) JP5001271B2 (xx)
KR (1) KR101390012B1 (xx)
CN (1) CN101500570B (xx)
AU (1) AU2007255724B2 (xx)
BR (1) BRPI0713104A2 (xx)
CA (1) CA2653827C (xx)
ES (1) ES2456328T3 (xx)
HK (1) HK1137344A1 (xx)
MX (1) MX2008015794A (xx)
RU (1) RU2445959C2 (xx)
WO (1) WO2007142295A1 (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101766626B (zh) * 2008-12-30 2012-03-07 丽珠医药集团股份有限公司 一种治疗精神分裂症的含布南色林的口服制剂
US8815261B2 (en) * 2009-06-19 2014-08-26 Medrx Co., Ltd. Composition for external application comprising aripiprazole and organic acid as active ingredients
JP5039871B2 (ja) * 2010-12-22 2012-10-03 大日本住友製薬株式会社 溶出制御した経口液剤
JP5818709B2 (ja) * 2011-02-02 2015-11-18 日東電工株式会社 貼付製剤
WO2012105715A1 (en) * 2011-02-02 2012-08-09 Dainippon Sumitomo Pharma Co., Ltd. Novel external preparation
ES2642274T3 (es) 2011-02-02 2017-11-16 Nitto Denko Corporation Preparación de parche
EP2671588A4 (en) * 2011-02-02 2014-10-01 Dainippon Sumitomo Pharma Co TRANSDERMALES PLASTER
WO2012105623A1 (ja) * 2011-02-02 2012-08-09 日東電工株式会社 貼付製剤の製造方法
WO2012105625A1 (ja) * 2011-02-02 2012-08-09 大日本住友製薬株式会社 経皮吸収促進剤及びそれを含有する経皮吸収型製剤
JP2012158572A (ja) * 2011-02-02 2012-08-23 Nitto Denko Corp 貼付製剤の製造方法
EP2599478A1 (de) * 2011-11-30 2013-06-05 Acino AG Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff davon
CA2828588C (en) * 2012-09-28 2020-10-27 Nitto Denko Corporation Patch preparation containing amine oxide
US9914848B1 (en) 2016-10-31 2018-03-13 Ppg Architectural Finishes, Inc. Refinish coating composition
MX2019007389A (es) 2016-12-20 2019-08-16 Lts Lohmann Therapie Systeme Ag Sistema terapeutico transdermico que contiene asenapina y polisiloxano o poliisobutileno.
US20180193283A1 (en) 2016-12-20 2018-07-12 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
JP2020525545A (ja) 2017-06-26 2020-08-27 エルテーエス ローマン テラピー−ジステーメ アーゲー アセナピンおよびシリコーンアクリルハイブリッドポリマーを含有する経皮治療システム
CN109516953A (zh) * 2017-09-18 2019-03-26 北京万全德众医药生物技术有限公司 布南色林工艺杂质的制备
CA3101420A1 (en) 2018-06-20 2019-12-26 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
WO2020047241A1 (en) * 2018-08-29 2020-03-05 Intra-Cellular Therapies, Inc. Novel compositions and methods
JPWO2021157457A1 (xx) * 2020-02-05 2021-08-12
EP4151215B1 (en) * 2020-05-14 2024-10-02 Kaneka Corporation Blonanserin-containing patch and production method therefor
KR102373703B1 (ko) * 2020-06-30 2022-03-11 최소영 수용성 점착제의 제조방법
KR102586379B1 (ko) 2021-07-15 2023-10-06 (주)켐코바이오 약물전달 조절이 가능한 패치용 점착제 조성물 및 그 조성물을 이용한 패치
EP4434525A1 (en) * 2021-11-15 2024-09-25 artience Co., Ltd. Adhesive patch containing selexipag as active ingredient

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0747574B2 (ja) * 1989-03-03 1995-05-24 大日本製薬株式会社 ピリジン誘導体及びそれを有効成分とする向精神剤
DE69010232T2 (de) * 1989-03-03 1994-12-01 Dainippon Pharmaceutical Co 2-(1-Piperazinyl)-4-phenylcycloalkanpyridin-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten.
JPH0499768A (ja) * 1990-08-17 1992-03-31 Dainippon Pharmaceut Co Ltd ４―（４―フェニルピリジン―２―イル）ピペラジン―１―オキシド誘導体
JP3274579B2 (ja) * 1995-01-12 2002-04-15 住友製薬株式会社 脳血管障害に伴う精神症候治療剤
TW592729B (en) 1995-04-06 2004-06-21 Janssen Pharmaceutica Nv Rate-controlled transdermal administration of risperidone
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine
TW587938B (en) * 1997-03-27 2004-05-21 Akzo Nobel Nv Pharmaceutical composition for the treatment and/or prophylaxis of psychotic disorder
CA2431041A1 (en) * 2001-01-02 2002-07-11 Pharmacia & Upjohn Company New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents
US20020123490A1 (en) * 2001-03-01 2002-09-05 Pfizer Inc. Combination treatment for anxiety, depression, obsessive compulsive disorder and psychosis
EP1480629A1 (en) * 2002-02-08 2004-12-01 Abbott Laboratories Combination therapy for treatment of schizophrenia
WO2005009510A2 (en) 2003-07-23 2005-02-03 The Regents Of The University Of California Penetration enhancer combinations for transdermal delivery
JPWO2006025516A1 (ja) 2004-09-03 2008-05-08 大日本住友製薬株式会社 ペロスピロン経皮投与用医薬組成物
DE602005010812D1 (de) * 2004-11-22 2008-12-18 Hisamitsu Pharmaceutical Co Transdermales Pflaster enthaltend einen schmelzpunktsenkenden Hilfsstoff
WO2007035942A2 (en) * 2005-09-23 2007-03-29 Alza Corporation Transdermal risperidone delivery system

Also Published As

Publication number Publication date
RU2008152758A (ru) 2010-07-20
WO2007142295A1 (ja) 2007-12-13
CA2653827C (en) 2014-04-08
BRPI0713104A2 (pt) 2012-10-16
EP2036559A4 (en) 2013-02-20
AU2007255724A1 (en) 2007-12-13
CN101500570A (zh) 2009-08-05
KR20090031407A (ko) 2009-03-25
MX2008015794A (es) 2009-01-12
AU2007255724B2 (en) 2012-05-10
US20090169605A1 (en) 2009-07-02
JP5001271B2 (ja) 2012-08-15
ES2456328T3 (es) 2014-04-22
CA2653827A1 (en) 2007-12-13
KR101390012B1 (ko) 2014-04-29
EP2036559A1 (en) 2009-03-18
US8354121B2 (en) 2013-01-15
RU2445959C2 (ru) 2012-03-27
CN101500570B (zh) 2012-07-04
JPWO2007142295A1 (ja) 2009-10-29
EP2036559B1 (en) 2014-03-19

Similar Documents

Publication Publication Date Title
HK1137344A1 (en) Tape preparation
ZA200808639B (en) Oxadiazolidinedione compound
GB2448061B (en) Improved tape measure
EP2114895A4 (en) TALARAZOLMETABOLITEN
DE602007002070D1 (en) 2-pyrazincarboxamidderivate
EP1985620A4 (en) COMPOUND 10a-AZALIDE
EP2030936A4 (en) ROLE
EP2047845A4 (en) ADHESIVE PREPARATION
EP2042174A4 (en) PREPARATION OF ADHESIVE
EP2007950A4 (en) RIBBON
EP2000469A4 (en) ACYLAMINOPIPERIDINVERBINDUNG
GB0600318D0 (en) Tape measures
GB0607096D0 (en) Compound
AP2008004724A0 (en) Substituted1-yl)-azolin-2-aryl-1-hetaryl-ethane
EP1999052A4 (en) BAND DONORS
EP2030937A4 (en) ROLE
GB0621911D0 (en) Tape measures
GB0604142D0 (en) Compound
GB0602939D0 (en) Tape
HK1134477A1 (en) Tape cutter
EP2085088A4 (en) ADHESIVE PREPARATION
DE502007001126D1 (en) Eiten
GB0619811D0 (en) Tape measures
GB0600317D0 (en) Tape measures
GB0600319D0 (en) Tape measures